Sestak I, Regan M, Dodson A, et al. Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy. SABCS 2017, GS6-01.
Neoadjuvant FOLFIRINOX versus gemcitabine-chemoradiotherapie bij (borderline) resectabel pancreascarcinoom
nov 2025 | Chirurgie, Maag-darm-leveroncologie